Skip to main content
Have a personal or library account? Click to login
Endocarditis in Adults with Congenital Heart Disease Cover

Endocarditis in Adults with Congenital Heart Disease

Open Access
|Jun 2026

References

  1. Li M, Kim JB, Sastry BKS, Chen M. Infective endocarditis. Lancet. 2024 Jul 27;404(10450):377-392. doi: 10.1016/S0140-6736(24)01098-5
  2. Delgado V, Marsan NA, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042. doi: 10.1093/eurheartj/ehad193
  3. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645. doi: 10.1093/eurheartj/ehaa554
  4. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009 Oct;30(19):2369-2413. doi: 10.1093/eurheartj/ehp285
  5. Havers-Borgersen E, Butt JH, Smerup M, et al. Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot. J Am Heart Assoc. 2021 Nov 16;10(22):e022445. doi: 10.1161/JAHA.121.022445
  6. Mylotte D, Rushani D, Therrien J, et al. Incidence, Predictors, and Mortality of Infective Endocarditis in Adults With Congenital Heart Disease Without Prosthetic Valves. Am J Cardiol. 2017 Dec 15;120(12):2278-2283. doi: 10.1016/j.amjcard.2017.08.051
  7. Havers-Borgersen E, Butt JH, Østergaard L, et al. Long-term incidence of infective endocarditis among patients with congenital heart disease. Am Heart J. 2023 May:259:9-20. doi: 10.1016/j.ahj.2023.01.012
  8. Snygg-Martin U, Giang KW, Dellborg M, Robertson J, Mandalenakis Z. Cumulative Incidence of Infective Endocarditis in Patients with Congenital Heart Disease: A Nationwide, Case-Control Study Over Nine Decades. Clin Infect Dis. 2021 Oct 20;73(8):1469-1475. doi: 10.1093/cid/ciab478
  9. Knirsch W, Nadal D. Infective endocarditis in congenital heart disease. Eur J Pediatr. 2011 Sep;170(9):1111-1127. doi: 10.1007/s00431-011-1520-8
  10. Rodbard S. Blood velocity and endocarditis. Circulation. 1963 Jan:27:18-28. doi: 10.1161/01.cir.27.1.18
  11. Popov DA, Vostrikova TYu, Rogova TV, Magandalieva AS, Kerefova MA. Carriage of antibiotic-resistant bacteria and etiology of postoperative infectious complications in infants with congenital heart defects. CMAC. 2022;24(2):139-146. doi: 10.36488/cmac.2022.2.139-146
  12. Goldmuntz E. 22q11.2 deletion syndrome and congenital heart disease. Am J Med Genet C Semin Med Genet. 2020 Mar;184(1):64-72. doi: 10.1002/ajmg.c.31774
  13. Cavalcanti NV, Palmeira P, Jatene MB, de Barros Dorna M, Carneiro-Sampaio M. Early Thymectomy Is Associated With Long-Term Impairment of the Immune System: A Systematic Review. Front Immunol. 2021 Nov 25:12:774780. doi: 10.3389/fimmu.2021.774780
  14. Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J. 2011 Aug;32(15):1926-1934. doi: 10.1093/eurheartj/ehq485
  15. Niwa K, Nakazawa M, Tateno S, Yoshinaga M, Terai M. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart. 2005 Jun;91(6):795-800. doi: 10.1136/hrt.2004.043323
  16. van der Linde, Konings EEM, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011 Nov 15;58(21):2241-2247. doi: 10.1016/j.jacc.2011.08.025
  17. Berglund E, Johansson B, Dellborg M, et al. High incidence of infective endocarditis in adults with congenital ventricular septal defect. Heart. 2016 Nov 15;102(22):1835-1839. doi: 10.1136/heartjnl-2015-309133
  18. Gurvitz M, Krieger EV, Fuller S, et al. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Feb 24;153(8):e115-e251. doi: 10.1161/CIR.0000000000001402
  19. Pereira SC, Abrantes AL, António PS, et al. Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2023 Jul 28:47:101249. doi: 10.1016/j.ijcha.2023.101249
  20. Williams ML, Brookes JDL, Jaya JS, Tan E. Homograft Versus Valves and Valved Conduits for Extensive Aortic Valve Endocarditis with Aortic Root Involvement/Destruction: A Systematic Review and Meta-Analysis. Aorta (Stamford). 2022 Apr;10(2):43-51. doi: 10.1055/s-0042-1743110
  21. Helal AM, Mashali MH, Elmahrouk AF, Galal MO, Jamjoom AA, Kouatli AA. Right ventricle to pulmonary artery conduit: a comparison of long-term graft-related events between bovine jugular vein conduit, aortic homograft, and porcine-valved conduits. Cardiovasc Diagn Ther. 2024 Feb 15;14(1):109-117. doi: 10.21037/cdt-23-364
  22. Kuijpers JM, Koolbergen DR, Groenink M, et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J. 2017 Jul 7;38(26):2048-2056. doi: 10.1093/eurheartj/ehw591
  23. Montanaro C, Dahill K, Frigiola A, Boyle S, Gatzoulis MA. The Fontan-infective endocarditis paradox: should patients with a Fontan circulation be counselled for antibiotic prophylaxis? Eur J Prev Cardiol. 2024 May 11;31(7):e47-e48. doi: 10.1093/eurjpc/zwad260
  24. Carvajal V, Reyes FB, Gonzalez D, Schwartz M, Whitlow A, Alegria JR. Endocarditis in Adult Congenital Heart Disease Patients: Prevention, Recognition, and Management. Curr Cardiol Rep. 2024 Sep;26(9):1031-1045. doi: 10.1007/s11886-024-02103-9
  25. Ong LT, Low FJK. Incidence and predictive factors of mortality of infective endocarditis in adults with congenital heart disease: A systematic review and meta-analysis. Int J Cardiol. 2024 Sep 1:410:132237. doi: 10.1016/j.ijcard.2024.132237
  26. Hsu AR, Karnakoti S, Abdelhalim AT, et al. Incidence and outcomes of prosthetic valve endocarditis in adults with congenital heart disease. Am Heart J. 2025 Apr:282:125-133. doi: 10.1016/j.ahj.2025.01.005
  27. McElhinney DB, Zhang Y, Aboulhosn JA, et al. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2021 Aug 10;78(6):575-589. doi: 10.1016/j.jacc.2021.05.044
  28. Lourtet-Hascoët J, Valdeolmillos E, Houeijeh A, et al. Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: Distinctive features. Arch Cardiovasc Dis. 2023 Mar;116(3):159-166. doi: 10.1016/j.acvd.2023.01.008
  29. Lewis MJ, Malm T, Hallbergson A, Odermarsky M, Luiba P. Prosthetic pulmonary valve infectious endocarditis in paediatric congenital heart disease patients. Interdiscip Cardiovasc Thorac Surg. 2025 Jun 4;40(6):ivaf102. doi: 10.1093/icvts/ivaf102
  30. Lehner A, Haas NA, Dietl M, et al. The risk of infective endocarditis following interventional pulmonary valve implantation: A meta-analysis. J Cardiol. 2019 Sep;74(3):197-205. doi: 10.1016/j.jjcc.2019.04.007
  31. Jin Q, Long Y, Zhang G, et al. Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract. Catheter Cardiovasc Interv. 2024 Feb;103(2):359-366. doi: 10.1002/ccd.30916
  32. Qureshi SA, Jones MI, Pushparajah K, et al. Transcatheter Pulmonary Valve Implantation Using Self-Expandable Percutaneous Pulmonary Valve System: 3-Year CE Study Results. JACC Cardiovasc Interv. 2025 Apr 28;18(8):1045-1056. doi: 10.1016/j.jcin.2024.12.031
  33. Goldstein BH, McElhinney DB, Gillespie MJ, et al. Early Outcomes From a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement Registry. J Am Coll Cardiol. 2024 Apr 9;83(14):1310-1321. doi: 10.1016/j.jacc.2024.02.010
  34. Dimas VV, Babaliaros V, Kim D, et al. Multicenter Pivotal Study of the Alterra Adaptive Prestent for the Treatment of Pulmonary Regurgitation. JACC Cardiovasc Interv. 2024 Oct 14;17(19):2287-2297. doi: 10.1016/j.jcin.2024.07.036
  35. Woods RK, Jaquiss RDB, May E. Caution with explant of prestented percutaneous pulmonary valves with infective endocarditis. JTCVS Tech. 2023 Mar 20:19:119-122. doi: 10.1016/j.xjtc.2023.03.003
  36. McElhinney DB, Zhang Y, Levi DS, et al. Reintervention and Survival After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2022 Jan 4;79(1):18-32. doi: 10.1016/j.jacc.2021.10.031
  37. Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020 Apr 1;22(4):515-549. doi: 10.1093/europace/euz246
  38. Baddour LM, Garrigos ZE, Sohail MR, et al. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases. Circulation. 2024 Jan 9;149(2):e201-e216. doi: 10.1161/CIR.0000000000001187
  39. Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med. 2019 May 16;380(20):1895-1905. doi: 10.1056/NEJMoa1901111
  40. van Melle JP, Roos-Hesselink JW, Bansal M, et al. Infective endocarditis in adult patients with congenital heart disease. Int J Cardiol. 2023 Jan 1:370:178-185. doi: 10.1016/j.ijcard.2022.10.136
  41. Brida M, Balint HO, Bence A, et al. Infective endocarditis in adults with congenital heart disease: Contemporary management and related outcomes in Central and South-Eastern European region. Int J Cardiol. 2023 Apr 15:377:45-50. doi: 10.1016/j.ijcard.2023.01.012
  42. Havers-Borgersen E, Østergaard L, Holgersson CK, et al. Infective endocarditis with or without congenital heart disease: clinical features and outcomes. Eur Heart J. 2024 Nov 21;45(44):4704-4715. doi: 10.1093/eurheartj/ehae548
  43. Müller N, Breuer J, Adler K, Freudenthal NJ. “Body modification: piercing and tattooing in congenital heart disease patients”, decoration or disaster?-a narrative review. Cardiovasc Diagn Ther. 2021 Dec;11(6):1395-1402. doi: 10.21037/cdt-21-458
DOI: https://doi.org/10.14797/mdcvj.1799 | Journal eISSN: 1947-6108
Language: English
Page range: 136 - 149
Submitted on: Feb 9, 2026
Accepted on: Apr 28, 2026
Published on: Jun 30, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2026 Andrea Busti, Giuseppe A. Annoni, Carlo Pace Napoleone, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.